Cargando…

A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors

To understand common but distinctive systems to drive oncogenic stages in human tumors is critical for understanding disease programme and developing novel therapeutic strategies. PBRM1 is a critical gene in oncogenesis. We found that PBRM1 is upregulated in multiple cancer genes. Prognostic analyse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jin, Xie, Xiaoli, Xue, Min, Wang, Jianqing, Chen, Qian, Zhao, Zhen, Sheng, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581638/ https://www.ncbi.nlm.nih.gov/pubmed/36277039 http://dx.doi.org/10.1155/2022/7676541

Ejemplares similares

Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Aili, Abudureyimujiang, et al.
Publicado: (2021)

Role of the Pbrm1 subunit and the PBAF complex in Schwann cell development
por: Polanetzki, Vanessa, et al.
Publicado: (2022)

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors
por: Zhao, Huihui, et al.
Publicado: (2022)

PBRM1 Regulates Stress Response in Epithelial Cells
por: Porter, Elizabeth G., et al.
Publicado: (2019)

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers
por: Dai, Jiali, et al.
Publicado: (2023)

PBRM1 suppresses tumor growth as a novel p53 acetylation reader
por: Cai, Weijia, et al.
Publicado: (2020)

PBRM1 bromodomains associate with RNA to facilitate chromatin association
por: De Silva, Saumya M, et al.
Publicado: (2023)

PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest
por: Huang, Li, et al.
Publicado: (2015)

PBRM1 and the glycosylphosphatidylinositol biosynthetic pathway promote tumor killing mediated by MHC-unrestricted cytotoxic lymphocytes
por: Menasche, Bridget L., et al.
Publicado: (2020)

PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth
por: Cai, Weijia, et al.
Publicado: (2019)

PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
por: Zhou, Mi, et al.
Publicado: (2022)

An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors
por: Wu, Biao, et al.
Publicado: (2021)

Oncogenic role and drug sensitivity of ETV4 in human tumors: a pan-cancer analysis
por: Zhang, Rui, et al.
Publicado: (2023)

The oncogenic role of SNRPB in human tumors: A pan-cancer analysis
por: Wu, Juan, et al.
Publicado: (2022)

An Integrative Pan-Cancer Analysis of PBK in Human Tumors
por: Wen, Huantao, et al.
Publicado: (2021)

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
por: Liu, Xian-De, et al.
Publicado: (2020)

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
por: Carril-Ajuria, Lucía, et al.
Publicado: (2019)

Pbrm1 intrinsically controls the development and effector differentiation of iNKT cells
por: Wang, Xin, et al.
Publicado: (2022)

Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft
por: Passeri, Thibault, et al.
Publicado: (2022)

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2017)

PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma
por: He, Xujun, et al.
Publicado: (2022)

Comprehensive analyses of PBRM1 in multiple cancer types and its association with clinical response to immunotherapy and immune infiltrates
por: Yang, Qiuan, et al.
Publicado: (2021)

A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors
por: Su, Rong, et al.
Publicado: (2022)

Oncogenic role of TWF2 in human tumors: A pan-cancer analysis
por: Liu, Wenjie, et al.
Publicado: (2022)

A pan-cancer analysis of the oncogenic role of YKT6 in human tumors
por: Zhang, Xuezhong, et al.
Publicado: (2023)

A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors
por: Ding, Qiang, et al.
Publicado: (2023)

PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2’-Deoxycytidine
por: Gu, Di, et al.
Publicado: (2022)

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis
por: Espana-Agusti, Judit, et al.
Publicado: (2017)

PBRM1 Cooperates with YTHDF2 to Control HIF-1α Protein Translation
por: Shmakova, Alena, et al.
Publicado: (2021)

Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma
por: Murakami, A, et al.
Publicado: (2017)

Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma
por: Zhou, Zhiyi, et al.
Publicado: (2022)

Integrative analysis of the role of BOLA2B in human pan-cancer
por: Liang, Mingxing, et al.
Publicado: (2023)

In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice
por: Li, Bin E., et al.
Publicado: (2023)

Non‑small cell lung cancer carrying PBRM1 mutation suggests an immunologically cold phenotype leading to immunotherapy failure even with high TMB
por: Miao, Xia-ye, et al.
Publicado: (2022)

PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer
por: Zhou, Huaqiang, et al.
Publicado: (2020)

A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors
por: Li, Ruiqi, et al.
Publicado: (2022)

A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumors
por: Mao, Shuai, et al.
Publicado: (2023)

Pan-cancer analysis connects tumor matrisome to immune response
por: Lim, Su Bin, et al.
Publicado: (2019)

PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma
por: Saiga, Kazuho, et al.
Publicado: (2022)

Pan-cancer analysis of CXCR4 carcinogenesis in human tumors
por: Wang, Sen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o6v5l3q140k6cl4hd0aem3fa34